BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30334465)

  • 1. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes.
    Ramos-Zayas Y; Franco-Molina MA; Hernádez-Granados AJ; Zárate-Triviño DG; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Ramírez-Romero R; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):48-54. PubMed ID: 30334465
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
    Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic potential of three transmissible venereal tumor cell lysates to prime canine-dendritic cells for cancer immunotherapy.
    Hernández-Granados AJ; Franco-Molina MA; Coronado-Cerda EE; Zapata-Benavides P; Gamboa EM; Ramos-Zayas Y; Santana-Krímskaya SE; Rodríguez-Padilla C
    Res Vet Sci; 2018 Dec; 121():23-30. PubMed ID: 30316013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
    Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
    Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.
    Pai CC; Kuo TF; Mao SJ; Chuang TF; Lin CS; Chu RM
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):187-99. PubMed ID: 21051091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
    Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
    Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
    Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
    Hsiao YW; Liao KW; Hung SW; Chu RM
    Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of MHC expression and retention of ultrastructural characteristics by xenograft transmissible venereal tumor cells in SCID mice.
    Harmelin A; Pinthus JH; Friedmann-Morvinski D; Kaufman K; Brenner O
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):245-9. PubMed ID: 12007890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
    Mukaratirwa S; Gruys E
    Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth.
    Pérez J; Day MJ; Mozos E
    Vet Immunol Immunopathol; 1998 Jul; 64(2):133-47. PubMed ID: 9661263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
    do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
    Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
    Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
    Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
    Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
    Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
    Delcayre A; Shu H; Le Pecq JB
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
    Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
    J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine transmissible venereal tumor (TVT): a review.
    Vermooten MI
    J S Afr Vet Assoc; 1987 Sep; 58(3):147-50. PubMed ID: 3334057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model.
    Yu WY; Chuang TF; Guichard C; El-Garch H; Tierny D; Laio AT; Lin CS; Chiou KH; Tsai CL; Liu CH; Li WC; Fischer L; Chu RM
    Vaccine; 2011 Apr; 29(18):3489-500. PubMed ID: 21392590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a murine xenograft model for canine transmissible venereal tumor.
    Harmelin A; Pinthus JH; Katzir N; Kapon A; Volcani Y; Amariglio EN; Rehavi G
    Am J Vet Res; 2001 Jun; 62(6):907-11. PubMed ID: 11400849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.